ACMPR

Access to Cannabis for Medical Purposes

 
 
 

ACMPR is an acronym for “Access to Cannabis for Medical Purposes Regulations“, also known as Canada's medical cannabis law. The Access to Cannabis for Medical Purposes Regulations are promulgated under the Controlled Drugs and Substances Act.

On August 24, 2016, in response to Justice Phelan’s judgment in the case of Allard v Canada ("Allard"), Health Canada implemented the Access to Cannabis for Medical Purposes Regulations (the "ACMPR"), replacing the Marihuana for Medical Purposes Regulations (the "MMPR"). 

The ACMPR also incorporates the various exemptions issued by Health Canada pursuant to the Controlled Drugs and Substances Act (the “CDSA”).

 

 

The ACMPR allows Canadians to:

  • Grow their own product/personal supply of medicinal cannabis;
  • Designate another individual to grow for them;
  • Purchase their medicinal cannabis through a licensed producer.

Under the ACMPR, patients with the correct documentation from their physician can purchase medical cannabis from special Health Canada-licensed producers.

Currently, the ACMPR works through mailorder only, which means that a patient has to place an order online or over the phone with a licensed producer, and then the licensed producer will ship the order directly to the patient through a courier service.